9136 Erlotinib as a second-line therapy in advanced non small cell lung cancer: correlation between clinical characteristics and biomarkersV. Rotella,F. Mazzoni,N. Pratesi,L. Simi,C. Orlando,L. Boni,C. E. Comin,C. Maddau,F. Di CostanzoEJC SUPPLEMENTS(2009)引用 2|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要